Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 4, 2006, Pages 389-396

  Chrysanthos, Nikolaos V ^a   Papatheodoridis, George V ^a   Savvas, Savvas ^a   Kafiri, Georgia ^b   Petraki, Kalliopi ^a   Manesis, Emanuel K ^a   Archimandritis, Athanasios J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b KAT HOSPITAL   (Greece)

Author keywords

APRI; Chronic hepatitis B; Chronic hepatitis C; Cirrhosis; Fibrosis

Indexed keywords

ASPARTATE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN;

ADULT; AREA UNDER THE CURVE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT;

ASPARTATE AMINOTRANSFERASES; FEMALE; GREECE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS;

EID: 33645110149     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200604000-00012     Document Type: Conference Paper

References (36)

1. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344:495-500.
2. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22:696-699.
3. Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68.276 biopsies. J Hepatol 1986; 2:165-173.
4. Garcia-Tsao G, Boyer JL. Outpatient liver biopsy: how safe is it? Ann Intern Med 1993; 118:150-153.
5. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38:1356-1358.
6. Caturelli E, Giacobbe A, Facciorusso D, Bisceglia M, Villani MR, Siena DA, et al. Percutaneous biopsy in diffuse liver disease: increasing diagnostic yield and decreasing complication rate by routine ultrasound assessment of puncture site. Am J Gastroenterol 1996; 91:1318-1321.
7. Papatheodoridis GV, Patch D, Watkinson A, Tibballs J, Burroughs AK. Tranjugular liver biopsies in the nineties: a two year audit. Aliment Pharmacol Ther 1999; 13:603-608.
8. Guechot J, Laudat A, Loria A, Serfaty L, Poupon R, Giboudeau J, et al. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem 1996; 42:558-563.
9. Kaul V, Friedenberg FK, Braitman LE, Anis U, Zaeri N, Fazili J, et al. Development and validation of a model to diagnose cirrhosis in patients with hepatitis C. Am J Gastroenterol 2002; 97:2623-2628.
10. George J. Biochemical markers of hepatic fibrogenesis: single measurements are not reliable enough to replace liver biopsy. J Gastroenterol Hepatol 2000; 15:819-821.
11. Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hassanein T. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol 2001; 96:3142-3146.
12. ImbertBismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357:1069-1075.
13. Forns X, Ampurdanes S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002; 36:986-992.
14. Wai CT, Greenson JK, Fontana RJ, Kalbfleish JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38:518-526.
15. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128:343-350.
16. Papatheodoridis GV, Hadziyannis SJ. Current management of chronic hepatitis B. Aliment Pharmacol Ther 2004; 19:25-37.
17. National Institute of Health Consensus Development Conference Statement: Management of hepatitis C: 2002 - June 10-12, 2002. Hepatology 2002; 36 (suppl 1):S3-S20.
18. Papatheodoridis GV, Cholongitas E. Chronic hepatitis C and no response to antiviral therapy: potential current and future therapeutic options. J Viral Hepatol 2004; 11:287-296.
19. Sud A, Hui JM, Farrell GC, Bandara P, Kench JG, Fung C, et al. Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index. Hepatology 2004; 39:1239-1247.
20. Dienstag JL. The role of liver biopsy in chronic hepatitis C. Hepatology 2002; 36:S152-S160.
21. Fontana RJ, Lok AS. Noninvasive monitoring of patients with chronic hepatitis C. Hepatology 2002; 36:S57-S64.
22. Poynard T, Munteanu M, Imbert-Bismut F, Charlotte F, Thabut D, Le Calvez S, et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 2004; 50:1344-1355.
23. Poynard T, Ratziu V, Benmanov Y, DiMartino V, Bedossa P, Opolon R. Fibrosis in patients with chronic hepatitis C: detection and significance. Semin Liver Dis 2000, 20:47-55.
24. Giannini E, Testa R. Noninvasive diagnosis of fibrosis: the truth is rarely pure and never simple. Hepatology 2003; 38:1312-1313.
25. Sheth SG, Flamm SL, Gordon FD, Chopra S. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1998; 93:44-48.
26. Piton A, Poynard T, Imbert-Bismuth F, Khalil L, Delattre J, Pelissier E, et al. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. Multivirc Group. Hepatology 1998; 27:1213-1219.
27. Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002; 137:1-10.
28. Poynard T, McHutchison J, Manns M, Myers RP, Albrecht J. Biochemical surrogate markers of liver fibrosis and activity in a randomised trial of peg-interferon alfa-2b and ribavirin. Hepatology 2003; 38:481-492.
29. Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, Contreras R. Nonivasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med 2004; 10:429-434.
30. Myers RP, Tainturier MH, Ratziu V, Piton A, Thibault V, Imbert-Bismut F, et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol 2003; 39:222-230.
31. Poynard T, Zoulim F, Ratziu V, Degos F, Imbert-Bismut F, Deny P, et al. Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection. Am J Gastroenterol 2005; 100:1970-1980.
32. Le Calvez S, Thabut D, Messous D, Munteanu M, Ratziu V, Imbert-Bismut F, et al. The predictive value of Fibrotest vs APRI for the diagnosis in chronic hepatitis C. Hepatology 2004; 39:862-863.
33. Poynard T. Diagnosis method of inflammatory, fibrotic or cancerous disease using the biochemical markers. United States Patent No US 6,631,330 B1, 2003.
34. Rossi E, Adams L, Prins A, Bulsara M, de Boer B, Garas G, et al. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem 2003; 49:450-454.
35. Lackner C, Struber G, Liegl B, Liebl S, Ofner P, Bankuti C, et al. Comparison and validation of simple non-invasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology 2005; 41:1376-1382.
36. Colletta C, Smirne C, Fabris C, Toniutto P, Rapetti R, Minisini R, et al. Value of two non-invasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 2005; 42:838-845.